ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0904

Testing the Hand Function with a Sensor-engineered Glove in Patients with Rheumatoid Arthritis

Alberto Sulli1, Guglielmo Bruzzone1, Paolo Vittoriano Clini1, Luca Carmisciano2, Tamara Vojinovic1, andrea cere1, sabrina Paolino1, Emanuele Gotelli1 and Maurizio Cutolo1, 1Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genova, Italy, 2Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genova, Genova, Italy

Meeting: ACR Convergence 2022

Keywords: Disease Activity, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Small joints of hands in rheumatoid arthritis (RA) are usually involved from the beginning, slowing the fine finger movements and inducing progressive reduction in joint function1. The Hand Test System (HTS) is a sensor-engineered glove tested for the evaluation of different aspects of hand function2. The aim of this study was to investigate the utility of HTS glove in analysing the speed of finger fine movements in RA patients and to test the correlation with clinical indexes of disease activity and the Health Assessment Questionnaire – Disease Index (HAQ-DI).

Methods: Thirty-three RA patients with stable disease (F/M 31/2, mean age 62 years, mean disease duration 15 years) performed HTS glove analysis at two different times; the mean time between measurements was 12±7 months. The engineered glove detects the maximum speed of finger movements and their variations between different measurements, that seem to be effective parameters of hand disability2. The glove hand function testing provides three quantitative parameters: touch duration (TD), inter-tapping interval (ITI) and movement rate (MR). These variables were correlated with HAQ-DI, 28-joint Disease Activity Score-C Reactive Protein (DAS28-CRP), Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) acquired at both time of measurements. Obtained data were analysed with t-test, Pearson’s test, scatter plot and linear regression. On the basis of the obtained results, a new composite score, combining HAQ and ITI, was also created. The linear regression was used to combine the two independent parameters (the subjective HAQ and the objective ITI) by reducing them to the same order of magnitude and creating a new composite score (HAQ+ITI), along the lines of DAS28-CRP, thus allowing to assess the patient hand status as a whole. The different effects of therapies were not considered in the present report.

Results: The correlation between the ITI glove data and the clinical scale scores was found only moderate (Pearson coefficient = 0.3). However, the composite score HAQ+ITI showed a significant correlation with DAS28-CRP (Pearson coefficient = 0.8) (p= 0.00018), CDAI (Pearson coefficient= 0.73) (p= 0.0001), SDAI (Pearson coefficient= 0.729) (p= 0.0001) and HAQ-DI scores (Person coefficient= 0.724) (p=0.0001) at both observational times.

Conclusion: The HTS glove seems to offer a new safe and easy tool for evaluating hand joint function by measuring the speed of finger movements in RA patients. The significant correlation between the composite score (HAQ+ITI) and other clinical indexes of disease activity, seems to improve the assessment of the impact of the disease on patient health status, overcoming the limit of the operator-dependent bias.

References: 1. Smolen JS, et al. Nat Rev Dis Primers 2018;4:18001. 2 Patanè M, et al. Joint Bone Spine 2022; 89(1):105272.


Disclosures: A. Sulli, LABORATORY BALDACCI SPA; G. Bruzzone, None; P. Clini, None; L. Carmisciano, None; T. Vojinovic, None; a. cere, None; s. Paolino, None; E. Gotelli, None; M. Cutolo, Bristol-Myers Squibb(BMS), Boehringer-Ingelheim, Amgen.

To cite this abstract in AMA style:

Sulli A, Bruzzone G, Clini P, Carmisciano L, Vojinovic T, cere a, Paolino s, Gotelli E, Cutolo M. Testing the Hand Function with a Sensor-engineered Glove in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/testing-the-hand-function-with-a-sensor-engineered-glove-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/testing-the-hand-function-with-a-sensor-engineered-glove-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology